Welcome to our dedicated page for Stonex Group SEC filings (Ticker: SNEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for StoneX Group Inc. (NASDAQ: SNEX), a Fortune 50 global financial services company. Through these filings, investors can review StoneX’s official disclosures on results of operations, financial condition, capital structure, acquisitions, and other material events.
StoneX’s current reports on Form 8-K cover a range of topics. Some filings report quarterly and annual financial results, referencing press releases that detail operating revenues, net income, segment performance, and key operating metrics such as listed derivatives contract volumes, OTC derivatives volumes, securities average daily volume, FX/CFD activity, payments volumes, and interest and fees earned on client balances. Other 8-Ks describe significant corporate transactions, including the acquisition of RTS Investor Corp., parent of the R.J. O’Brien global business, and related financing arrangements.
Filings also document StoneX’s entry into material definitive agreements, such as the Indenture governing senior secured notes due 2032 issued by a wholly owned subsidiary in connection with the R.J. O’Brien acquisition. These documents outline terms including maturity, interest rate, redemption provisions, guarantees, collateral, and covenants that affect StoneX’s capital structure and obligations. Additional 8-Ks discuss share repurchase authorizations approved by the Board of Directors and prospectus supplements registering the resale of common stock issued as acquisition consideration.
On Stock Titan, StoneX filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI-powered summaries help explain the significance of lengthy documents such as annual reports on Form 10-K and quarterly reports on Form 10-Q, highlighting segment results, revenue composition, and risk factors. For current reports on Form 8-K, AI analysis can surface key items, including acquisitions, debt offerings, stock repurchase plans, and earnings releases.
Investors can also use this page to track insider and equity-related disclosures when available, such as unregistered sales of equity securities reported in 8-Ks, and to understand how StoneX structures its financing and manages regulatory requirements. By combining raw filings with AI-generated insights, this page is intended to make StoneX’s regulatory reporting more accessible to both professional and individual investors.
KASS STEVEN A reported acquisition or exercise transactions in this Form 4 filing.
StoneX Group Inc. director Steven A. Kass received an award of 1,101 restricted shares of common stock as part of his annual compensation for non-executive directors. The shares were granted at no cash cost and will fully vest on the first anniversary of the grant date. Following this award, Kass directly holds 36,757 shares.
BEXIGA ANNABELLE G reported acquisition or exercise transactions in this Form 4 filing.
StoneX Group Inc. director Annabelle G. Bexiga received a grant of 1,101 restricted shares of common stock as part of her annual non-executive director compensation. The shares vest fully on the first anniversary of the grant date, bringing her direct holdings to 17,459 shares after a non-material correction related to a prior 3:2 stock split.
StoneX Group Inc. Chief Information Officer Abigail H. Perkins reported option and stock transactions on February 13, 2026. She exercised stock options for 8,000 shares at a stated exercise price of $27.58 per share and received 8,000 shares of common stock.
On the same date, she sold 8,000 shares of common stock in open-market transactions at an average price of $126.7161 per share, based on the filing’s footnote. After these transactions, she directly owned 48,259 common shares and indirectly held 337 shares through her children.
T. Rowe Price Associates, Inc. filed a Schedule 13G reporting beneficial ownership of 2,851,483 shares of StoneX Group Inc. common stock, representing 5.5% of the class as of 12/31/2025. T. Rowe Price reports sole voting power over 2,812,135 shares and sole dispositive power over 2,851,468 shares, with no shared voting or dispositive power.
The firm states the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of StoneX Group. The filing also notes that T. Rowe Price Associates expressly denies being the beneficial owner of the securities referred to, despite reporting them for Schedule 13G purposes.
StoneX Group Inc. filed a quarterly institutional holdings report detailing its investment positions. The firm reports that its Form 13F information table covers 1,087 separate equity and related holdings with a combined reported market value of $2,304,467,694, rounded to the nearest dollar.
The filing is a full 13F holdings report, meaning all reportable positions for StoneX Group Inc. and three related managers — StoneX Advisors Inc., StoneX Financial Inc., and Trust Advisory Group Ltd — are included. The report is signed by John Calvano, Chief Compliance Officer, on behalf of the reporting manager.
StoneX Group Inc. Executive Vice-Chairman Sean Michael O'Connor reported exercising stock options and selling common stock. On February 9, 2026, he exercised 40,000 stock options at an exercise price of $20 per share and acquired 40,000 shares of common stock, then sold 40,000 shares in open-market transactions at an average price of $124.9475.
On February 10, 2026, he again exercised 40,000 stock options at $20 per share and sold 40,000 shares of common stock at an average price of $124.5615. After these transactions, he directly owned 854,127 common shares and 1,045,000 stock options, and indirectly held 282,902 shares through a trust and 1,695,976 shares through Darseaker Limited.
StoneX Group Inc. chief risk officer Mark L. Maurer reported an option exercise and share sale involving the company’s common stock. On February 9, 2026, he exercised 40,000 stock options at an exercise price of $20 per share, acquiring the same number of common shares.
On the same date, he then sold 40,000 common shares in an open-market transaction at an average price of $124.878 per share, as disclosed in a footnote. After these transactions, he directly owned 90,331 common shares and 410,000 stock options.
SNEX insider Sean O'Connor has filed a notice to sell 40,000 shares of common stock. The planned sale is through Merrill Lynch on the NASDAQ around February 10, 2026, with an aggregate market value of $4,949,320 based on the filing.
These 40,000 shares were acquired on February 10, 2026 via stock plan activity from the issuer. The filing also notes that O'Connor sold another 40,000 common shares on February 9, 2026, generating gross proceeds of $4,996,698 over the prior three months.
StoneX Group Inc. insider activity: President Charles M. Lyon exercised stock options for 45,000 shares of common stock at $20 per share on February 9, 2026, then sold 30,000 common shares at an average price of $124.7757 per share. After these transactions, he directly owned 150,330 shares of common stock and 337,500 stock options.
SenesTech Inc. (SNEX) filed a notice of proposed sale under Rule 144 for 30,000 shares of its common stock through Merrill Lynch on NASDAQ. The filing lists an aggregate market value of 3,742,369 for these shares, with 52,463,316 shares outstanding.
The 30,000 common shares were acquired on 02/09/2026 through stock plan activity from the issuer, with the payment date also on 02/09/2026. The seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.